Healthcare provider profile · identity verified

Kishalay Sinha, MD

Family Practice · LAUDERDALE LAKES, FL · NPI 1285292136

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	355	136
Amlodipine Besylate	Amlodipine Besylate	314	133
Rosuvastatin Calcium	Rosuvastatin Calcium	306	143
Losartan Potassium	Losartan Potassium	304	116
Pantoprazole Sodium	Pantoprazole Sodium	260	139
Azithromycin	Azithromycin	259	188
Gabapentin	Gabapentin	236	118
Albuterol Sulfate Hfa	Albuterol Sulfate	223	122
Fluticasone Propionate	Fluticasone Propionate	215	117
Prednisone	Prednisone	191	119
Metformin Hcl	Metformin Hcl	183	78
Lisinopril	Lisinopril	176	72
Diclofenac Sodium	Diclofenac Sodium	155	116
Glipizide	Glipizide	153	55
Trazodone Hcl	Trazodone Hcl	139	69
Metoprolol Succinate	Metoprolol Succinate	124	54
Tramadol Hcl	Tramadol Hcl	124	51
Levothyroxine Sodium	Levothyroxine Sodium	123	54
Ibuprofen	Ibuprofen	116	74
Ozempic	Semaglutide	116	29
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	113	41
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	112	82
Carvedilol	Carvedilol	112	49
Alprazolam	Alprazolam	100	32
Tamsulosin Hcl	Tamsulosin Hcl	100	53
Furosemide	Furosemide	97	59
Ondansetron Odt	Ondansetron	95	78
Warfarin Sodium	Warfarin Sodium	90	24
Omeprazole	Omeprazole	88	56
Duloxetine Hcl	Duloxetine Hcl	87	46
Alendronate Sodium	Alendronate Sodium	83	31
Metoprolol Tartrate	Metoprolol Tartrate	83	37
Zolpidem Tartrate	Zolpidem Tartrate	79	18
Triamcinolone Acetonide	Triamcinolone Acetonide	72	59
Baclofen	Baclofen	71	43
Meloxicam	Meloxicam	71	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	28
Ezetimibe	Ezetimibe	64	28
Glimepiride	Glimepiride	59	26
Lactulose	Lactulose	59	42
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	34
Hydrochlorothiazide	Hydrochlorothiazide	51	26
Oxybutynin Chloride Er	Oxybutynin Chloride	51	32
Montelukast Sodium	Montelukast Sodium	50	28
Sertraline Hcl	Sertraline Hcl	48	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	18
Eliquis	Apixaban	46	12
Finasteride	Finasteride	41	13
Cephalexin	Cephalexin	40	38
Famotidine	Famotidine	40	26
Sildenafil Citrate	Sildenafil Citrate	39	14
Nifedipine Er	Nifedipine	37	16
Temazepam	Temazepam	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	19
Quetiapine Fumarate	Quetiapine Fumarate	36	16
Allopurinol	Allopurinol	35	13
Jardiance	Empagliflozin	35	suppressed
Naproxen	Naproxen	35	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Valsartan	Valsartan	33	15
Latanoprost	Latanoprost	32	11
Escitalopram Oxalate	Escitalopram Oxalate	31	11
Meclizine Hcl	Meclizine Hcl	31	22
Simvastatin	Simvastatin	31	15
Atenolol	Atenolol	30	12
Clonazepam	Clonazepam	30	suppressed
Fluconazole	Fluconazole	30	16
Citalopram Hbr	Citalopram Hydrobromide	29	11
Hydroxyzine Hcl	Hydroxyzine Hcl	28	21
Hydralazine Hcl	Hydralazine Hcl	27	13
Pioglitazone Hcl	Pioglitazone Hcl	26	11
Spironolactone	Spironolactone	26	11
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	25	suppressed
Nitroglycerin	Nitroglycerin	23	18
Pregabalin	Pregabalin	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	16
Oxybutynin Chloride	Oxybutynin Chloride	21	14
Benazepril Hcl	Benazepril Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	16
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Lumigan	Bimatoprost	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	13
Trulicity	Dulaglutide	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methimazole	Methimazole	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error